NO20081045L - Forbindelser og fremgangsmater for behandling av cancer - Google Patents

Forbindelser og fremgangsmater for behandling av cancer

Info

Publication number
NO20081045L
NO20081045L NO20081045A NO20081045A NO20081045L NO 20081045 L NO20081045 L NO 20081045L NO 20081045 A NO20081045 A NO 20081045A NO 20081045 A NO20081045 A NO 20081045A NO 20081045 L NO20081045 L NO 20081045L
Authority
NO
Norway
Prior art keywords
compounds
methods
treating cancer
leukemia
potent
Prior art date
Application number
NO20081045A
Other languages
English (en)
Norwegian (no)
Inventor
Paul Gutsch
Brian Renzelmann
Original Assignee
Ziopharm Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziopharm Oncology Inc filed Critical Ziopharm Oncology Inc
Publication of NO20081045L publication Critical patent/NO20081045L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20081045A 2005-07-29 2008-02-28 Forbindelser og fremgangsmater for behandling av cancer NO20081045L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70416305P 2005-07-29 2005-07-29
PCT/US2006/029835 WO2007027344A2 (en) 2005-07-29 2006-07-28 Compounds and methods for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20081045L true NO20081045L (no) 2008-04-25

Family

ID=37809342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081045A NO20081045L (no) 2005-07-29 2008-02-28 Forbindelser og fremgangsmater for behandling av cancer

Country Status (8)

Country Link
US (3) US7968738B2 (https=)
EP (2) EP1919564B1 (https=)
JP (1) JP4994374B2 (https=)
AU (1) AU2006285329B2 (https=)
CA (1) CA2617049A1 (https=)
ES (2) ES2531159T3 (https=)
NO (1) NO20081045L (https=)
WO (1) WO2007027344A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4994374B2 (ja) 2005-07-29 2012-08-08 ジオファーム オンコロジー， インコーポレイテッド がんを治療するための化合物および方法
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
CN101903029B (zh) * 2007-11-02 2012-09-26 Zio医药肿瘤学公司 使用有机砷化物的联合治疗
WO2009075870A1 (en) * 2007-12-12 2009-06-18 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
PT2321012T (pt) * 2008-08-20 2019-01-11 Solasia Pharma K K Compostos organoarsénicos e métodos para o tratamento de cancro
KR20150056848A (ko) 2012-09-20 2015-05-27 요게시 나라얀 벤데일 나노 삼산화비소의 생합성 방법 및 이의 암을 포함한 질환의 치료 용도
CN105899486A (zh) * 2013-12-05 2016-08-24 日本苏爱康制药有限公司 用于治疗癌症的化合物和方法
EP3269402B1 (en) * 2015-03-12 2025-10-22 Adeka Corporation Anti-adhesion material and substitute biomembrane using decellularized tissue
CN107167433A (zh) * 2016-03-07 2017-09-15 天津国际生物医药联合研究院 一种检测氯二甲基砷的方法
JPWO2019220961A1 (ja) * 2018-05-18 2020-05-28 ソレイジア・ファーマ株式会社 ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277819B1 (en) * 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
US6875451B2 (en) * 1997-10-15 2005-04-05 Polarx Biopharmaceuticals Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
TR200002243T2 (tr) 1997-11-10 2000-12-21 Memorial Sloan-Kettering Cancer Center Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
EP1049486A4 (en) * 1997-12-05 2006-01-04 Lilly Co Eli GLP-1 FORMULATIONS
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
SE9802080D0 (sv) * 1998-06-11 1998-06-11 Hellstroem Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
US7022315B2 (en) * 2000-04-26 2006-04-04 Oregon Health & Science University Administration of a thiol-based chemoprotectant compound
EP1474128B1 (en) * 2002-01-07 2016-06-01 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid, s-dimethylarsino-2-thiobenzoic acid, s-(dimethylarsino)glutathione as treatments for cancer
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
JP4994374B2 (ja) 2005-07-29 2012-08-08 ジオファーム オンコロジー， インコーポレイテッド がんを治療するための化合物および方法
CN101903029B (zh) * 2007-11-02 2012-09-26 Zio医药肿瘤学公司 使用有机砷化物的联合治疗

Also Published As

Publication number Publication date
ES2531159T3 (es) 2015-03-11
ES2532666T3 (es) 2015-03-30
HK1164767A1 (en) 2012-09-28
AU2006285329A1 (en) 2007-03-08
AU2006285329A2 (en) 2008-08-14
WO2007027344A3 (en) 2007-12-21
US8865764B2 (en) 2014-10-21
EP2394702A1 (en) 2011-12-14
US7968738B2 (en) 2011-06-28
EP1919564A2 (en) 2008-05-14
EP2394702B1 (en) 2014-12-31
WO2007027344A2 (en) 2007-03-08
HK1117780A1 (en) 2009-01-23
JP4994374B2 (ja) 2012-08-08
US20130142730A1 (en) 2013-06-06
AU2006285329B2 (en) 2012-10-04
JP2009502971A (ja) 2009-01-29
EP1919564B1 (en) 2014-11-26
CA2617049A1 (en) 2007-03-08
US8334398B2 (en) 2012-12-18
US20120022229A1 (en) 2012-01-26
US20070183972A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
NO20081045L (no) Forbindelser og fremgangsmater for behandling av cancer
TW200616615A (en) Compounds and methods for the treatment of cancer
WO2011098262A3 (en) P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
SG151267A1 (en) Carboline derivatives useful in the inhibition of angiogenesis
NO20075918L (no) Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
NZ597075A (en) 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer
WO2005113747A3 (de) Multizelluläre gewebe- und organkultursysteme
WO2006058014A3 (en) Harnessing network biology to improve drug discovery
UA98629C2 (ru) Соединения и способ модуляции киназ
MY139942A (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
RU2711869C3 (ru) Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
BRPI0607306A2 (pt) derivados de quinoxalina como agentes anti-tumor
UY29826A1 (es) Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones
NL2000375A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
MY146112A (en) Long-term feed - cancer patient
TNSN07369A1 (en) Heteroaryl urea derivatives useful for inhibiting chki
DE602005019762D1 (de) Medizinisches Instrument zum Manipulieren, insbesondere zum Zurückziehen des Gewebes oder des Organes.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
WO2007118751A3 (de) Verfahren zur veränderung des atp-adp-verhältnisses in zellen
IL186121A0 (en) Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
EP4328319A3 (en) Methods and compositions for identifying and treating patients with small cell lung cancer
DE60004027D1 (de) Organische-arsenverbindungen
TW200731991A (en) Lipophilic di(anticancer drug) compounds, compositions and related methods

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application